Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Sarepta Therapeutics Inc patents

Recent patent applications related to Sarepta Therapeutics Inc. Sarepta Therapeutics Inc is listed as an Agent/Assignee. Note: Sarepta Therapeutics Inc may have other listings under different names/spellings. We're not affiliated with Sarepta Therapeutics Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Sarepta Therapeutics Inc-related inventors




Date Sarepta Therapeutics Inc patents (updated weekly) - BOOKMARK this page
07/13/17Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
06/08/17Splice-region antisense composition and method
02/23/17Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human lmna
12/29/16Functionally-modified oligonucleotides and subunits thereof
12/08/16Inhibitory oligonucleotides and their use in therapy
10/13/16Exon skipping compositions for treating muscular dystrophy
09/29/16Antisense composition and treating muscle atrophy
09/01/16Antibacterial antisense oligonucleotide and method
08/18/16Peptide oligonucleotide conjugates
07/21/16Antisense-induced exon2 inclusion in acid alpha-glucosidase
04/14/16Oligonucleotide analogues targeting human lmna
02/11/16Exon skipping compositions for treating muscular dystrophy
01/07/16Multiple exon skipping compositions for dmd
01/07/16Multiple exon skipping compositions for dmd
01/07/16Multiple exon skipping compositions for dmd
12/31/15Multiple exon skipping compositions for dmd
12/31/15Multiple exon skipping compositions for dmd
12/24/15Antisense modulation of nuclear hormone receptors
12/17/15Exon skipping compositions for treating muscular dystrophy
12/03/15Inhibitory oligonucleotides and their use in therapy
09/24/15Antisense antiviral compound and treating ss/rna viral infection
08/20/15Splice-region antisense composition and method
07/16/15Antisense-induced exon2 inclusion in acid alpha-glucosidase
07/02/15Immunosuppression compound and treatment method
06/04/15Multiple exon skipping compositions for dmd
05/21/15Compound and treating myotonic dystrophy
05/07/15Oligonucleotide compound and treating nidovirus infections
04/30/15Antisense composition and treating muscle atrophy
03/19/15Compound and treating myotonic dystrophy
03/19/15Boronic acid conjugates of oligonucleotide analogues
03/12/15Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
02/05/15Oligonucleotide analog and treating flavivirus infections
11/06/14Compositions for treating muscular dystrophy
11/06/14Induced exon inclusion in spinal muscle atrophy
11/06/14Exon skipping compositions for treating muscular dystrophy
11/06/14Functionally-modified oligonucleotides and subunits thereof
10/30/14Exon skipping compositions for treating muscular dystrophy
10/23/14Compositions for treating muscular dystrophy
10/23/14Exon skipping compositions for treating muscular dystrophy
10/09/14Antisense antiviral compound and treating influenza viral infection
10/09/14Oligonucleotides for treating expanded repeat diseases
10/02/14Methods and compositions for manipulating translation of protein isoforms from alternative initiation of start sites
09/25/14Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis
07/31/14Antibacterial antisense oligonucleotide and method
07/10/14Immunosuppression compound and treatment method
04/17/14Compound and treating myotonic dystrophy
04/03/14Multiple exon skipping compositions for dmd
02/13/14Splice-region antisense composition and method
01/23/14Oligonucleotide analogues targeting human lmna
10/31/13Dsrna molecules comprising oligonucleotide analogs having modified intersubunit linkages and/or terminal groups
07/25/13Multiple exon skipping compositions for dmd







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Sarepta Therapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Sarepta Therapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';